DIVIS LABORATORIES
Back to Income Statement
|
DIVIS LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit After Tax | ₹1,600 Cr | ₹1,824 Cr | ₹2,960 Cr | ₹1,984 Cr | ₹1,377 Cr |
What is the latest Profit After Tax of DIVIS LABORATORIES ?
Year | Profit After Tax |
---|---|
Mar2024 | ₹1,600 Cr |
Mar2023 | ₹1,824 Cr |
Mar2022 | ₹2,960 Cr |
Mar2021 | ₹1,984 Cr |
Mar2020 | ₹1,377 Cr |
How is Profit After Tax of DIVIS LABORATORIES Trending?
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2024 | ₹1,600 Cr | -12.28 | |
Mar2023 | ₹1,824 Cr | -38.39 | |
Mar2022 | ₹2,960 Cr | 49.19 | |
Mar2021 | ₹1,984 Cr | 44.15 | |
Mar2020 | ₹1,377 Cr | - |
Compare Profit After Tax of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹158,673.4 Cr | 2.4% | 2.2% | 59.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,617.0 Cr | -2.1% | -9% | 9.1% | Stock Analytics | |
CIPLA | ₹119,511.0 Cr | 1.4% | 2% | 0.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹104,734.0 Cr | -0.9% | -2.8% | 16.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,705.1 Cr | -2.1% | -9.2% | -8.7% | Stock Analytics | |
MANKIND PHARMA | ₹96,821.9 Cr | -2.1% | -10.9% | 7.9% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.4% |
2.2% |
59.7% |
SENSEX | -0.4% |
-1.4% |
5.4% |
You may also like the below Video Courses